What we did
Based on the client's ask, the team divided the study into two phases:
Phase 1: Identifying various business opportunities in the ophthalmic domain.
- What are the various new approaches or technologies in the ophthalmic domain, e.g. ophthalmic drug delivery systems available?
- Who are the key players in this space? (Companies, Universities, etc.)
- Activity from competitors of J&J or major players active in the ophthalmic domain, including patent filing, collaborations, JVs, Joint research programs, etc.
Assessment of the technology based on the technical parameters, for example:
- Rate of delivery, sustained/ delayed action, targeted delivery to retinal layers, drug delivery barriers, therapeutic dose index in specific eye parts and associated complications, and pharmacokinetics? What are the Regulatory approvals, Recalls, etc.
- What specific type of disease state is being treated and associated with disease complications, and what specific type of drug molecules and their formulation?
- User-friendliness of the solution – comfort, ease of administration, reusability, etc.
Assessment of the business opportunity associated with the recommended solution:
- The potential addressable market of the solution? The growth potential associated with the recommended solution?
- Why do we believe this to be a good opportunity?
Possible implementation roadmap, including:
- Who could be potential partners for setting up joint ventures and partnerships?
- Any possible licensing/technology transfer opportunities for the technology?
Phase 2: Was a business case prepared on the top selected recommendations from Phase 1 and it focus on the following:
- Brief Introduction of business opportunity
- Profitability earn by business opportunity
- Opportunity description
- Technology summary
- Key advantages of the technology
- Key benefits of business opportunity
- Comparative analysis of selected business opportunities, for e.g. SWOT analysis
- Future growth of J&J based on business opportunity